Dry Skin Coping Strategies
Dry skin is a common problem among GIST patients. There are many things that you can do to alleviate dry skin caused by GIST treatment. Keep reading for more info. Dry Skin Coping Strategies: Using [...]
Necrosis of the Jaw Coping Strategies
Necrosis of the jaw has been reported to occur in some patients receiving bisphophonate therapy. There have been several reports of possible drug interaction between sunitinib (Sutent) and bisphophonates that significantly increases the risk of necrosis [...]
Edema Coping Strategies
Between fifty to seventy percent of GIST patients participating in Gleevec clinical trials are reported to have edema according to the Life Raft Group survey (October, 2001) and www.gleevec.com. Edema can develop in different [...]
Mouth Sores – Coping Strategies
Mouth sores, or stomatitis as it is referred to in medical textbooks, can develop as a result of cancer treatment. There are many ways to help prevent and reduce the occurrence of mouth sores. How [...]
Increased Tearing – Epiphoria Coping Strategies
Increased tearing, or epiphoria, can be a side effect of your GIST treatment. There are a number of strategies to cope with increased tearing. Keep reading for more information. Here are a few strategies [...]
Hand and Foot Syndrome Coping Strategies
Hand and Foot Syndrome coping strategies. Although targeted cancer therapies are generally considered to have less side effects than traditional chemotherapy, the need to take these drugs for extended time periods (in many cases [...]
Muscle Cramps – Coping Strategies
Updated 2/9/2022 Muscle cramps can occur during cancer treatment, and it is a common side effect patients in our Patient Registry experience. GIST Treatments including Gleevec, Sutent, Stivarga, Qinlock and Ayvakit can cause a [...]
Stivarga Approved to Treat GIST Patients in Japan
Stivarga has just been approved in Japan for the treatment of GIST. Keep reading for more information.Official Stivarga Press Release:Bayer HealthCare has received approval from the Japanese authorities (MHLW) for the marketing of Regorafenib (Stivarga) [...]
The GIST Cancer Journal – First Journal Specifically focused on GIST
The GIST Cancer Journal is the first journal specifically focused on Gastrointestinal Stromal Tumors (GIST). Keep reading for more information.The GIST Cancer Journal Official Press Release:CONTACT/MEDIA INQUIRIES: Erin Kristoff, Marketing and Communications DirectorThe Life Raft GroupWayne Plaza [...]
Alianza GIST sets forth plan for strengthening the coalition in Latin America
Alianza GIST has set forth a plan to strengthen the coalition in Latin America. Keep reading for the official press release and more information about Alianza GIST.